㈜한빔테크놀로지
 
 
HOME > NOTICE
 


 
작성일 : 13-12-23 08:38
World’s First MEVION S250 Proton Therapy Treatment Delivered at Barnes-Jewish Hospital
 글쓴이 : 최고관리자
조회 : 7,582  
   http://www.mevion.com/news/105--worlds-first-mevion-s250-proton-therap… [1443]
Landmark event represents a new era in radiation therapy.

ST. LOUIS, M.O., December 19, 2013/BUSINESSWIRE/ -- A patient with a rare type of cancer
called chondrosarcoma at the base of the skull has become the first person in the world to
receive proton therapy using the revolutionary MEVION S250 Proton Therapy System from
Mevion Medical Systems, Inc. of Littleton, MA. Radiation oncologists at the Siteman Cancer
Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis
delivered the treatment. The S. Lee Kling Proton Therapy Center at Barnes-Jewish Hospital is
home to the MEVION S250, a unique proton therapy device designed to deliver the same
precise, non-invasive treatments delivered by conventional proton systems but with a greatly
reduced physical footprint, streamlined clinical workflow, and significantly lower implementation
and operational costs.
“We are extremely pleased and proud to open the Kling Proton Therapy Center for the St. Louis
community and beyond.” said Rich Liekweg, President of Barnes-Jewish Hospital. The closest
proton therapy center is over 230 miles away from St. Louis. “The ability to add proton therapy
to our world-class cancer care program in a significantly smaller and more economical package
is imperative in today’s challenging health care environment. Barnes-Jewish Hospital is the first
in the world to operate a single-room proton therapy system and the addition of this advanced
technology continues our tradition of providing the best care for our patients.”
Proton therapy delivers highly precise doses of radiation while limiting unnecessary radiation to
healthy tissue, potentially decreasing radiation side effects and improving patient outcomes.
Mevion’s ability to provide this advanced treatment in a compact form is an industry first, leading
the way in providing patients and clinicians access to proton therapy without the high entry and
maintenance costs plaguing conventional proton systems. “Today’s important landmark event
represents the beginning of a new era in proton radiation therapy. The ability to treat with this
advanced technology is no longer encumbered by astronomical costs, prohibitive space
requirements, and technologically cumbersome systems that to date have defined this treatment
modality” stated Joseph K. Jachinowski, Chief Executive Officer of Mevion Medical Systems.
“The MEVION S250 proves that all the benefits and more of these legacy proton therapy
systems can be delivered in a fiscally responsible manner”.
The pioneering proton team at the Kling Proton Therapy Center has been working diligently for
the past several months running the MEVION S250 through independent and rigorous clinical
quality assurance tests to ensure that system specifications, safety, and reliability requirements
are met. “The advanced clinical workflow provided by the MEVION S250 and its full integration
within the clinic has made it simple and straightforward to train the radiation therapy staff and
prepare their clinic for day-to-day treatments”, said Dr. Stanley Rosenthal, Vice President of
Clinical Systems and Education. “The initial training experience of the therapists demonstrates
that the MEVION S250 workflow and delivery times are comparable to today’s image-guided
radiation therapy techniques.”
“The teams from Barnes-Jewish Hospital and Mevion have worked tirelessly and diligently to
arrive at this seminal event. The opportunity to bring a revolutionary medical device into routine
clinical use that will improve the lives of many people around the globe isn’t something that
happens often. We have all been touched by this event and we couldn’t be prouder to be a part
of this team,” added Jachinowski.
Four additional MEVION S250 proton therapy systems are under installation at Robert Wood
Johnson University Hospital in New Brunswick, NJ, the Stephenson Cancer Center at
Oklahoma University in Oklahoma City, OK, First Coast Oncology in Jacksonville, FL and the
Proton Therapy Center at Orlando Health. In addition, the Seidman Cancer Center at University
Hospitals in Cleveland, OH broke ground on their MEVION S250 center in September of this
year, and has taken delivery of the first system module, thus making Mevion Medical Systems
the leading supplier of proton therapy in the USA.
[이 게시물은 최고관리자님에 의해 2013-12-23 08:39:48 News&Media에서 이동 됨]